Home
/ Invitae
/ Competitors

Invitae Competitors and Similar CompaniesClear all

Invitae's competitors and similar companies include Natera, Quest Diagnostics, Bio-Reference Laboratories, Ambry Genetics and Biora Therapeutics.

	Invitae Invitae is a company engaged in medical genetic testing.	Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.	Quest Diagnostics Quest Diagnostics is a company that provides diagnostic information solutions.	Bio-Reference Laboratories BioReference is a clinical diagnostic laboratory offering scientific expertise and laboratory innovation in oncology, urology, and women’s health.	Ambry Genetics Ambry Genetics is a company that provides genetic testing solutions.	Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services.
Founding Date	Founding Date 2010	Founding Date 2004	Founding Date 1967	Founding Date 1981	Founding Date 1999	Founding Date 2010
Type	Type Subsidiary	Type Public	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech genetics medical diagnostics	Tags Healthcare genetics healthtech medical diagnostics women's health	Tags Healthcare clinical research medical diagnostics medical imaging	Tags Healthcare medical diagnostics oncology platform women's health	Tags Healthcare biotech genetics medical diagnostics	Tags Healthcare biotech drug development
Locations	Locations San Francisco, US HQ	Locations Austin, US HQ San Carlos, US	Locations Secaucus, US HQ São Paulo, BR Hyderabad, IN Dublin, IE Ciudad De México, MX	Locations Elmwood Park, US HQ Houston, US	Locations Aliso Viejo, US HQ Aliso Viejo, US	Locations San Diego, US HQ San Diego, US
Employees	Employees 8601% decrease	Employees 3,28211% increase	Employees 57,0002% increase	Employees 1,856	Employees 9094% increase	Employees 5456% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 15.4 b	Valuation ($) 17.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 16.4 m
Financial
Revenue (est.)	Revenue (est.) $516.3m (FY, 2022)	Revenue (est.) $2.3b (FY, 2025)	Revenue (est.) $11b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $4k (FY, 2023)
Cost of goods	Cost of goods $417.3m (FY, 2022)	Cost of goods N/A	Cost of goods $7.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $99m (FY, 2022)	Gross profit N/A	Gross profit $3.7b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($3.1b) (FY, 2022)	Net income ($208.2m) (FY, 2025)	Net income $1b (FY, 2025)	Net income N/A	Net income N/A	Net income ($124.1m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 363.1m	Total funding raised $ 154.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 138.5m